• 1
    Beech J. Tumor of the pituitary gland (pars intermedia). In: RobinsonNE, ed. Current Therapy in Equine Medicine, 2nd ed. Philadelphia , PA : WB Saunders; 1987;182185.
  • 2
    Dybdal NO. Endocrine disorders. In: SmithB., ed. Large Animal Internal Medicine. St. Louis , MO : CV Mosby; 1990;12961302.
  • 3
    Gribble DH. The endocrine system. In: CatcottEJ, SmithcorsJF, eds. Equine Medicine and Surgery. Santa Barbara , CA : American Veterinary Publications; 1972;433442.
  • 4
    Orth DN, Holscher MA, Wilson MG, et al. Equine Cushing's Disease, Plasma immunoreactive proopiolipo-melanocortin peptides and cortisol levels basally and in response to diagnostic tests. Endocrinology 1982; 110:14301441.
  • 5
    Wilson MG, Nicholson WE, Holscher MA, et al. Proopiolipo-melanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses. Endocrinology 1982; 110: 941954.
  • 6
    Aron DC, Tyrell JB. Glucocorticoids and adrenal androgens. In: GreenspanFS, BaxterJD, eds. Basic and Clinical Endocrinology, 4th ed. Nonvalk , CT : Appleton & Lange; 1994;307346.
  • 7
    Orth DN, Nicholson WE. Bioactive and immunoreactive adre-nocorticotropin in normal equine pituitary and In pituitary tumors of horses with Cushing's disease. Endocrinology 1982; 111:559563.
  • 8
    Hogan P., Rees LH, Lowry PJ, et al. Studies on the stability of human adrenocorticotrophin in blood and plasma. J Endocrinol 1976;71:6364.
  • 9
    Hegstad RL, Johnston SD, Pasternack DM. Effects of sample handling on adrenocorticotropin concentration measured in canine plasma, using a commercially available radioimmunoassay kit. Am J Vet Res 1990;51:19411947.
  • 10
    Chattoraj SC, Watts NB. Endocrinology. In: TietzNW, ed. Fundamentals of Clinical Chemistry, 3rd edition. Philadelphia , PA : WB Saunders; 1987:533613.
  • 11
    James VHT, Horner MW, Moss MS, et al. Adrenocortical function in the horse. J Endocrinol 1970;48:319335.
  • 12
    Eyre P., Elmes PJ, Strickland S. Corticosteroid-potentiated vascular response of the equine digit: A possible pharmacological basis for laminitis. Am J Vet Res 1979;40:135138.
  • 13
    Glantz SA. Primer of Biostatistics, 3rd ed. New York , NY : McGraw Hill; 1992.
  • 14
    Irvine CHG, Alexander SL. A novel technique for measuring hypothalamic and pituitary hormone secretion rates from collection of pituitary venous effluent in the normal horse. J Endocnnol 1987; 113:1183192.
  • 15
    Klein MJ, Deegen E., Moogen H., et al. Funktionstest der equinen Nebennierenrinde. Pferdeheilkunde 1989;5:225230.
  • 16
    Redekopp C., Irvine CHG, Donald RA, et al. Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse. Endocrinology 1986; 118: 14101416.
  • 17
    Jeffcott L., Field JR, McLean J., et al. Glucose tolerance test and insulin sensitivity in ponies and standardbred horses. Equine Vet J 1986;18:97101.
  • 18
    Robie SM, Janson CH, Smith SC, et al. Equine serum lipids: Serum lipids and glucose in Morgan and thoroughbred and Shetland ponies. Am J Vet Res 1975;36:17051708.
  • 19
    McCarthy RN, Jeffcott LB, Funder JN, et al. Plasma beta-endorphin and adrenocoiticotrophin in young horses in training. Australian Vet J 1991;68:359361.
  • 20
    Alexander SL, Irvine CHG, Livesey JH, et al. Effect of isolation stress on concentration of arginine vasopressin, a-melanocyte-stimulating hormone and ACTH in the pituitary venous effluent of the normal horse. J Endocrinol 1988; 116:325334.
  • 21
    Alexander SL, Irvine CHG, Ellis MJ, et al. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse. Endocrinology 1991; 128:6572.
  • 22
    Taylor PM. Equine stress responses to anesthesia. Br J Anaesth 1989;63:702709.
  • 23
    Hillyer MH, Taylor FGR, Mair TS, et al. Diagnosis of hyper-adrenocorticism in the horse. Equine Vet Educ 1992;4:131134.
  • 24
    Dybdal NO, Hargreaves KM, Madigan JE, et al. Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc 1994;204:627632.
  • 25
    Beech J. Evaluation of thyroid, adrenal and pituitary function. Vet Clin North Am (Equine Pract) 1987;3:649660.
  • 26
    Linden A., Art T., Amory H., et al. Comparison of the adrenocortical response to both pharmacological and physiological stresses in sport horses. J Vet Med Assoc 1990: 37:601604.
  • 27
    Heinrichs M., Baumgartner W., Capen CC. Immunocytochem-ical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses. Vet Pathol 1990;27:419425.
  • 28
    Amann JF, Smith RM, Ganjam VK, et al. Distribution and implications of β-endorphin and ACTH immunoreactive cells in the intermediate lobe of the hypophysis in healthy equids. Am J Vet Res 1987;48:323327.
  • 29
    Garcia MC, Beech J. Equine intravenous glucose tolerance test: Glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma. Am J Vet Res 1986;47:570572.
  • 30
    Mal ME, Friend TH, Lay DC, et al. Physiological responses of mares to short term confinement and social isolation. Equine Vet Science 1991; 11:96102.